AAAAAA

   
Results: 1-11 |
Results: 11
Aerosols and anti-infectious agents
Authors: Diot, P DeQuin, PF Rivoire, B Gagnadoux, F Faurisson, F Diot, E Boissinot, E Le Pape, A Palmer, L Lemarie, E
Citation: P. Diot et al., Aerosols and anti-infectious agents, J AEROSOL M, 14(1), 2001, pp. 55-64
Diabetic arteriopathy: microcirculation, an inevitable therapeutic objective.
Authors: Guilmot, JL Diot, E Boissier, C
Citation: Jl. Guilmot et al., Diabetic arteriopathy: microcirculation, an inevitable therapeutic objective., J MAL VASC, 26(2), 2001, pp. 135-141
Characterization of Tc-99m-DTPA aerosols for lung permeability studies
Authors: Diot, P Galinier, E Grimbert, D Bugeon, S Valat, C Lemarie, E Diot, E Baulieu, JL Besnard, JC Guilloteau, D
Citation: P. Diot et al., Characterization of Tc-99m-DTPA aerosols for lung permeability studies, RESPIRATION, 68(3), 2001, pp. 313-317
Strategy for early diagnosis of lung involvement in systemic sclerodermia
Authors: Diot, E Valat, C Boissinot, E Giraudeau, B Asquier, E Guilmot, JL Lemarie, E Diot, P
Citation: E. Diot et al., Strategy for early diagnosis of lung involvement in systemic sclerodermia, REV MAL RES, 17(6), 2000, pp. 1073-1080
Contribution of platelet antiaggregates in the prevention of complicationsof atherothrombosis
Authors: Guilmot, JL Diot, E Gruel, Y
Citation: Jl. Guilmot et al., Contribution of platelet antiaggregates in the prevention of complicationsof atherothrombosis, PRESSE MED, 29(13), 2000, pp. 709-716
Decrease in DL,CO in systemic sclerosis correlates with acceleration of DTPA clearance
Authors: Diot, E Giraudeau, B Maillot, F Diot, P
Citation: E. Diot et al., Decrease in DL,CO in systemic sclerosis correlates with acceleration of DTPA clearance, EUR RESP J, 14(3), 1999, pp. 728-728
Anti-infectious aerosols.
Authors: Diot, P Dequin, PF Rivoire, B Gagnadoux, F Faurisson, F Diot, E Boissinot, E Lemarie, E
Citation: P. Diot et al., Anti-infectious aerosols., REV MAL RES, 16(3), 1999, pp. 277-285
Role of drug therapy in critical ischemia of the lower limbs
Authors: Guilmot, JL Diot, E
Citation: Jl. Guilmot et E. Diot, Role of drug therapy in critical ischemia of the lower limbs, PRESSE MED, 28(12), 1999, pp. 647-650
Diabetic foot
Authors: Combe, H Lasfargues, G Diot, E Guilmot, JL
Citation: H. Combe et al., Diabetic foot, ANN DER VEN, 126(6-7), 1999, pp. 536-540
Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis?
Authors: Diot, E Giraudeau, B Diot, P Degenne, D Ritz, L Guilmot, JL Lemarie, E
Citation: E. Diot et al., Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis?, CHEST, 116(3), 1999, pp. 715-720
Relationship between abnormalities on high-resolution CT and pulmonary function in systemic sclerosis
Authors: Diot, E Boissinot, E Asquier, E Guilmot, JL Lemarie, E Valat, C Diot, P
Citation: E. Diot et al., Relationship between abnormalities on high-resolution CT and pulmonary function in systemic sclerosis, CHEST, 114(6), 1998, pp. 1623-1629
Risultati: 1-11 |